ANG Lifesciences India Ltd

AI
ANG Lifesciences Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

ANG Lifesciences India Ltd

₹ 25.6 4.97%
24 Aug 4:01 p.m.
anglifesciences.com BSE: 540694
About

Incorporated in 2006, ANG Lifesciences
India Ltd is in the business of pharmaceuticals products & formulations, and packaging and printing.[1]

Key Points

Business Overview:[1][2][3]
ANGLIL is a part of the ANG Group which is a WHO-GMP–certified consortium of pharmaceutical companies. The company is engaged in the manufacturing of pharmaceuticals & allied products which include finished formulations in Non-Beta Lactam, Beta Lactam, Cephalosporin, and Carbapenem segments.

Website BSE
  • Market Cap ₹ 33.4 Cr.
  • Current Price ₹ 25.6
  • High / Low ₹ 49.7 / 17.6
  • Stock P/E
  • Book Value ₹ 47.6
  • Dividend Yield 0.00 %
  • ROCE 0.95 %
  • ROE -7.33 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.54 times its book value
  • Company's working capital requirements have reduced from 55.3 days to 19.2 days

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -9.90% over past five years.
  • Company has a low return on equity of -9.97% over last 3 years.
  • Promoters have pledged 44.9% of their holding.
  • Company has high debtors of 260 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
50.61 29.58 17.10 34.08 16.18 32.16 23.91 17.67 24.53 25.97 18.30 22.80 13.96
44.94 28.26 18.82 30.23 18.11 29.70 25.89 18.03 22.67 23.75 20.37 18.18 15.42
Operating Profit 5.67 1.32 -1.72 3.85 -1.93 2.46 -1.98 -0.36 1.86 2.22 -2.07 4.62 -1.46
OPM % 11.20% 4.46% -10.06% 11.30% -11.93% 7.65% -8.28% -2.04% 7.58% 8.55% -11.31% 20.26% -10.46%
0.34 0.33 -0.09 -1.49 1.36 0.36 -0.03 0.75 0.17 0.21 0.16 0.19 0.19
Interest 1.94 1.96 1.99 3.44 1.67 1.87 1.71 2.05 1.61 1.59 1.61 1.65 1.77
Depreciation 1.94 1.97 2.02 1.83 1.51 1.62 1.84 1.30 1.45 1.45 1.45 1.73 1.47
Profit before tax 2.13 -2.28 -5.82 -2.91 -3.75 -0.67 -5.56 -2.96 -1.03 -0.61 -4.97 1.43 -4.51
Tax % 25.35% -10.09% -20.96% 23.71% -26.13% 61.19% -17.99% -34.46% -23.30% 29.51% -14.89% 23.08% -24.17%
1.60 -2.05 -4.59 -3.60 -2.77 -1.07 -4.57 -1.94 -0.79 -0.80 -4.24 1.10 -3.42
EPS in Rs 1.23 -1.57 -3.52 -2.76 -2.12 -0.82 -3.50 -1.49 -0.60 -0.61 -3.25 0.84 -2.62
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
36.84 54.92 66.93 75.13 121.27 126.08 154.24 348.52 206.82 131.30 89.73 91.60 81.03
33.72 50.19 60.43 67.83 109.63 113.65 138.91 282.98 195.15 121.75 90.75 84.99 77.72
Operating Profit 3.12 4.73 6.50 7.30 11.64 12.43 15.33 65.54 11.67 9.55 -1.02 6.61 3.31
OPM % 8.47% 8.61% 9.71% 9.72% 9.60% 9.86% 9.94% 18.81% 5.64% 7.27% -1.14% 7.22% 4.08%
0.09 0.21 0.25 0.69 0.23 0.42 0.75 0.95 9.84 -0.89 1.99 0.73 0.75
Interest 1.66 1.66 1.77 1.85 2.64 3.22 3.98 8.31 10.92 9.77 7.64 6.45 6.62
Depreciation 0.95 1.06 1.17 1.19 1.12 1.23 2.24 5.12 8.52 7.75 6.27 6.08 6.10
Profit before tax 0.60 2.22 3.81 4.95 8.11 8.40 9.86 53.06 2.07 -8.86 -12.94 -5.19 -8.66
Tax % 31.67% 25.23% 25.98% 24.65% 30.33% 27.50% 26.47% 25.18% 131.88% -2.48% -20.02% -8.86%
0.40 1.65 2.82 3.72 5.65 6.10 7.25 39.71 -0.66 -8.65 -10.34 -4.73 -7.36
EPS in Rs 0.43 1.79 3.07 2.86 4.35 4.69 5.58 30.55 -0.51 -6.62 -7.92 -3.62 -5.64
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.61% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: 5%
5 Years: -10%
3 Years: -24%
TTM: -18%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 12%
Stock Price CAGR
10 Years: %
5 Years: -32%
3 Years: -30%
1 Year: -11%
Return on Equity
10 Years: 9%
5 Years: 5%
3 Years: -10%
Last Year: -7%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 3.68 3.68 3.68 5.18 5.18 5.18 5.18 10.37 13.06 13.06 13.06 13.06
Reserves -0.57 1.09 3.81 17.99 23.58 29.37 36.17 73.11 72.48 64.01 53.75 49.16
10.15 11.77 14.01 17.42 21.90 20.83 42.40 60.99 55.56 59.36 70.58 66.84
12.59 18.95 25.34 27.57 30.24 38.69 58.49 124.21 111.40 81.00 71.28 60.85
Total Liabilities 25.85 35.49 46.84 68.16 80.90 94.07 142.24 268.68 252.50 217.43 208.67 189.91
8.78 9.02 8.90 9.47 20.60 20.94 21.89 82.32 78.68 53.35 52.63 47.05
CWIP 0.00 0.00 0.07 11.57 0.16 0.23 0.40 0.00 0.00 0.00 0.00 0.00
Investments 0.02 0.02 0.02 0.02 0.02 0.02 0.02 3.52 3.52 3.52 3.52 3.52
17.05 26.45 37.85 47.10 60.12 72.88 119.93 182.84 170.30 160.56 152.52 139.34
Total Assets 25.85 35.49 46.84 68.16 80.90 94.07 142.24 268.68 252.50 217.43 208.67 189.91

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
3.13 1.86 2.73 0.88 7.46 4.83 -11.18 27.39 26.01 -13.13 -2.29 13.72
-2.32 -2.92 -2.56 -13.40 -0.77 -1.66 -7.79 -42.50 -9.35 20.02 -1.63 -3.33
-0.89 1.63 -0.29 13.10 -3.80 -3.95 18.81 15.29 -16.75 -7.00 3.92 -10.19
Net Cash Flow -0.08 0.56 -0.12 0.57 2.89 -0.77 -0.16 0.17 -0.08 -0.12 -0.01 0.20
Free Cash Flow 2.43 0.55 1.61 -12.38 6.62 3.19 -15.25 -11.96 15.58 5.93 -6.41 9.63
CFO/OP 103% 48% 54% 26% 84% 60% -69% 43% 252% 3% -186% 208%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 62.22 108.86 139.39 156.19 125.66 133.34 139.10 103.67 137.85 192.56 264.24 260.40
Inventory Days 84.14 46.81 44.62 53.41 27.18 41.03 67.62 46.29 92.90 143.34 227.95 206.64
Days Payable 129.88 133.28 163.44 153.96 90.63 105.80 158.84 105.16 153.93 243.56 333.86 250.41
Cash Conversion Cycle 16.48 22.39 20.58 55.64 62.21 68.56 47.88 44.80 76.83 92.34 158.34 216.63
Working Capital Days 18.73 10.23 14.40 48.29 39.70 52.60 47.14 22.05 27.88 74.97 71.80 19.17
ROCE % 16.74% 26.04% 29.34% 21.90% 23.56% 21.92% 19.90% 53.78% 8.51% 1.78% -3.54% 0.95%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2023 Mar 2024 Mar 2025
Capacity Utilization of Dry Powder Vials
%

Log in to view insights

Please log in to see hidden values.

Login
Production volume of Dry Powder Vials
Lakhs Pieces
Export revenue (domiciled outside India)
Rs Lakhs
Number of permanent employees
count
Number of countries exporting to
count
Order book position
Rs crore
Revenue share - Government Institutions
% of total revenue
Revenue share - Third Party/Contract Manufacturing
% of total revenue

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
70.60% 70.60% 70.60% 70.60% 70.60% 70.60% 70.60% 70.60% 70.60% 70.60% 70.60% 70.60%
29.38% 29.41% 29.39% 29.39% 29.39% 29.39% 29.39% 29.39% 29.40% 29.40% 29.41% 29.40%
No. of Shareholders 7,3057,0556,9186,8686,6316,4686,5176,5086,4006,2736,0845,952

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls

  • Aug 2022
    Transcript
    AI Summary
    PPT
  • Feb 2022
    Transcript
    AI Summary
    PPT
  • Oct 2021
    Transcript
    AI Summary
    PPT
  • Sep 2021
    Transcript
    AI Summary
    PPT
  • Jun 2019
    Transcript
    AI Summary
    PPT